Growth hormone deficiency and vascular risk
暂无分享,去创建一个
[1] R. García-mayor,et al. Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain , 2001, Clinical endocrinology.
[2] R. Clayton,et al. Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults , 2001, Clinical endocrinology.
[3] M. Alpsten,et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. , 2001, The Journal of clinical endocrinology and metabolism.
[4] R. Clayton,et al. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities , 2001, Clinical endocrinology.
[5] T. Sasaoka,et al. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. , 2001, Diabetes.
[6] A. Atkinson,et al. Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy , 2001, Clinical endocrinology.
[7] L. Berglund,et al. Growth hormone and cardiovascular disease: an area in rapid growth. , 2001, The Journal of clinical endocrinology and metabolism.
[8] J. Després,et al. Treatment of obesity: need to focus on high risk abdominally obese patients , 2001, BMJ : British Medical Journal.
[9] N. Rifai,et al. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. , 2001, The Journal of clinical endocrinology and metabolism.
[10] R. Lanes,et al. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents. , 2001, The Journal of clinical endocrinology and metabolism.
[11] K. Wheatley,et al. Association between premature mortality and hypopituitarism , 2001, The Lancet.
[12] B. Capaldo,et al. Abnormal Vascular Reactivity in Growth Hormone Deficiency , 2001, Circulation.
[13] Maarten Boers,et al. Time to review policy on contraindications to vaccination , 2000, The Lancet.
[14] L. Hagmar,et al. Is Vascular Mortality Increased in Hypopituitarism? , 2000, Pituitary.
[15] T. Spinks,et al. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. , 2000, The Journal of clinical endocrinology and metabolism.
[16] Shalet. GH deficiency in the elderly: the case for GH replacement , 2000, Clinical endocrinology.
[17] S. Ramsay. Linking lipoprotein (a) and coronary heart disease , 2000, The Lancet.
[18] N. Rifai,et al. Effects of Growth Hormone Administration on Inflammatory and Other Cardiovascular Risk Markers in Men with Growth Hormone Deficiency , 2000, Annals of Internal Medicine.
[19] J. Kvasnička,et al. Increase of adhesion molecules, fibrinogen, type‐1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement , 2000, Clinical endocrinology.
[20] S. Shalet,et al. Modulation of cortisol metabolism by low-dose growth hormone replacement in elderly hypopituitary patients. , 2000, The Journal of clinical endocrinology and metabolism.
[21] S. Jackson,et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. , 2000, European journal of endocrinology.
[22] B. Bengtsson,et al. Treatment of growth hormone deficiency in adults. , 2000, The Journal of clinical endocrinology and metabolism.
[23] J. Jørgensen,et al. Insulin‐like growth factor I administration induces fluid and sodium retention in healthy adults: possible involvement of renin and atrial natriuretic factor , 2000, Clinical endocrinology.
[24] P. Cohen,et al. Insulin and insulin‐like growth factor‐I cause vasorelaxation in human vessels in vitro , 2000, Coronary artery disease.
[25] L. Hagmar,et al. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. , 2000, The Journal of clinical endocrinology and metabolism.
[26] R. Dietz,et al. Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. , 2000, Cardiovascular research.
[27] A. Lucas,et al. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group. , 1999, European journal of endocrinology.
[28] A. Dominiczak,et al. Endothelial function in hypertension: the role of superoxide anion. , 1999, Hypertension.
[29] S. Ashley,et al. The incidence of cerebrovascular accidents in patients with pituitary adenoma. , 1999, International journal of radiation oncology, biology, physics.
[30] M. Bernareggi,et al. Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat. , 1999, Journal of cardiovascular pharmacology.
[31] P. Sönksen,et al. Growth hormone (GH) replacement therapy reduces serum sialic acid concentrations in adults with GH‐deficiency: a double‐blind placebo‐controlled study , 1999, Clinical endocrinology.
[32] P. Chowienczyk,et al. Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity , 1999, Clinical endocrinology.
[33] E. Ghigo,et al. The growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. , 1999, The Journal of clinical endocrinology and metabolism.
[34] J. Goodfellow,et al. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency , 1999, Clinical endocrinology.
[35] M. Pfeifer,et al. Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[36] P. Stewart,et al. Life expectancy following surgery for pituitary tumours , 1999, Clinical endocrinology.
[37] C. Conover,et al. Characterization and partial purification of the insulin-like growth factor (IGF)-dependent IGF binding protein-4-specific protease from human fibroblast conditioned media. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[38] Leese,et al. HDL‐cholesterol reductions associated with adult growth hormone replacement , 1998, Clinical endocrinology.
[39] P. Malmström,et al. Postoperative prognosis in craniopharyngioma with respect to cardiovascular mortality, survival, and tumor recurrence. , 1998, The Journal of clinical endocrinology and metabolism.
[40] E. Ghigo,et al. Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults , 1998, Journal of endocrinological investigation.
[41] T. Spinks,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients , 2022 .
[42] L. Hagmar,et al. Cardiovascular mortality among pituitary insufficient patients , 1998, Clinical endocrinology.
[43] R. Rizza,et al. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro. , 1998, Hypertension.
[44] E. Arvat,et al. 10 Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects , 1998 .
[45] F. Alford,et al. 1 Growth hormone deficiency and cardiovascular risk , 1998 .
[46] J. Weaver,et al. Sexual dimorphism in 11 β hydroxysteroid dehydrogenase activity and its relation to fat distribution and insulin sensitivity; a study in hypopituitary subjects , 1998, Clinical endocrinology.
[47] M. Elam,et al. Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency. , 1998, The Journal of clinical endocrinology and metabolism.
[48] J. Loscalzo,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.
[49] E. Arvat,et al. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. , 1998, The Journal of clinical endocrinology and metabolism.
[50] C. Rantzau,et al. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. , 1998, The Journal of clinical endocrinology and metabolism.
[51] B. Bengtsson,et al. Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency , 1998, Clinical endocrinology.
[52] T. Johns,et al. Endothelial Dysfunction: Implications for Therapy of Cardiovascular Diseases , 1998, The Annals of pharmacotherapy.
[53] K. Noonan,et al. The effect of growth hormone replacement therapy on cortisol–cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β‐hydroxysteroid dehydrogenase activity , 1998, Clinical endocrinology.
[54] B. Biondi,et al. Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. , 1997, The Journal of clinical endocrinology and metabolism.
[55] B. Angelin,et al. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat. , 1997, The Journal of clinical investigation.
[56] J. Sowers,et al. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. , 1997, Hypertension.
[57] S. Wright,et al. Inhibitory effect of growth hormone on TNF-alpha secretion and nuclear factor-kappaB translocation in lipopolysaccharide-stimulated human monocytes. , 1997, Journal of immunology.
[58] K. Parker,et al. Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults. , 1997, European journal of endocrinology.
[59] L. Hagmar,et al. Increased cerebrovascular mortality in patients with hypopituitarism , 1997, Clinical endocrinology.
[60] G. Brabant,et al. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. , 1996, The Journal of clinical investigation.
[61] A. Blann,et al. Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectin. , 1996, Atherosclerosis.
[62] M. Sampson,et al. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. , 1996, Journal of the American College of Cardiology.
[63] B. Bengtsson,et al. Long-term Treatment with Growth Hormone Decreases Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator in Growth Hormone-deficient Adults , 1996, Thrombosis and Haemostasis.
[64] A. Tsatsoulis,et al. Increased Serum Lipoprotein(a) Concentrations after Growth Hormone (GH) Treatment in Patients with Isolated GH Deficiency , 1996, Annals of clinical biochemistry.
[65] D. O'Neal,et al. Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy. , 1996, The Journal of clinical endocrinology and metabolism.
[66] K. Petersen,et al. Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.
[67] R. Muniyappa,et al. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. , 1996, Endocrinology.
[68] R. Clayton,et al. The effect of hypopituitarism on life expectancy. , 1996, The Journal of clinical endocrinology and metabolism.
[69] A. Vaag,et al. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. , 1996, The Journal of clinical endocrinology and metabolism.
[70] B. A. Harder,et al. Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. , 1996, Journal of molecular and cellular cardiology.
[71] P. Durrington,et al. A Comparative Study of Six Commercial Lipoprotein(a) Assays in Seventeen Laboratories within the British Isles , 1996, Annals of clinical biochemistry.
[72] C. Piccinato,et al. Peripheral glucose metabolism in human hyperprolactinaemia , 1995, Clinical endocrinology.
[73] M. Gammage,et al. Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism , 1995, Clinical endocrinology.
[74] R. Baserga,et al. Stabile D‐peptide analog of insulin‐like growth factor‐l inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] J. Cohn,et al. Noninvasive pulse wave analysis for the early detection of vascular disease. , 1995, Hypertension.
[76] B. Bengtsson,et al. Growth hormone-deficient adults are insulin-resistant. , 1995, Metabolism: clinical and experimental.
[77] H. Koppeschaar,et al. Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. , 1995, The American journal of clinical nutrition.
[78] L. Sommese,et al. Effect of growth hormone, prolactin and insulin on the release of IL-1 alpha, IFN-gamma and IL-4 by staphylococcal enterotoxin A-stimulated splenocytes. , 1995, European cytokine network.
[79] P Vallance,et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. , 1995, Hypertension.
[80] S. Thompson,et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.
[81] H. de Boer,et al. Clinical aspects of growth hormone deficiency in adults. , 1995, Endocrine reviews.
[82] D. Johnston,et al. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. , 1995, The Journal of clinical endocrinology and metabolism.
[83] D. O'Neal,et al. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. , 1994, The Journal of clinical endocrinology and metabolism.
[84] P. Marzullo,et al. Growth hormone and the heart , 2001, Endocrine Updates.
[85] G. Watts,et al. The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients , 1994, Clinical endocrinology.
[86] A. Mengel,et al. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. , 1994, The Journal of clinical investigation.
[87] W. Hsueh,et al. Endothelial-Dependent Vascular Effects of Insulin and Insulin-Like Growth Factor I in the Perfused Rat Mesenteric Artery and Aortic Ring , 1994, Diabetes.
[88] L. Bach,et al. Hypertension and cardiac hypertrophy in growth hormone-deficient rats. , 1994, Clinical science.
[89] K. Nair,et al. Recombinant human insulin-like growth factor-I increases forearm blood flow. , 1994, The Journal of clinical endocrinology and metabolism.
[90] B. Angelin,et al. Growth hormone and hepatic lipoprotein metabolism. , 1994, Current opinion in lipidology.
[91] S. Shalet,et al. Growth hormone replacement in adults , 1994, BMJ.
[92] A. Nicolaides,et al. Carotid intima‐media thickness: correlation with the British Regional Heart Study risk score , 1994, Journal of internal medicine.
[93] A. O’Sullivan,et al. Diagnosis of growth-hormone deficiency in adults , 1994, The Lancet.
[94] K. Caidahl,et al. Cardiovascular and renal effects of growth hormone * , 1994, Clinical endocrinology.
[95] B. Tönshoff,et al. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. , 1994, Kidney international.
[96] B. Bengtsson,et al. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. , 1993, Metabolism: clinical and experimental.
[97] J. Christiansen,et al. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. , 1993, The Journal of clinical investigation.
[98] O. Silvennoinen,et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase , 1993, Cell.
[99] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[100] M. Elam,et al. Is sympathetic neural hyperactivity in chronic heart failure affected by heart transplantation? , 1993, European heart journal.
[101] L. Lönn,et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. , 1993, The Journal of clinical endocrinology and metabolism.
[102] K. D. Hopkins,et al. Aortic distensibility in growth hormone deficient adults , 1993, The Lancet.
[103] A. Nicolaides,et al. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults , 1992, The Lancet.
[104] J. K. Lloyd,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.
[105] P. Sönksen,et al. The growth hormone deficiency syndrome in adults , 1992, Clinical endocrinology.
[106] J. Gustafsson,et al. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[107] E. Boerwinkle,et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. , 1992, The Journal of clinical investigation.
[108] S. Lamberts,et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition , 1992, Clinical endocrinology.
[109] P. Björntorp. Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.
[110] C. Wiles,et al. Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system. , 1991, Clinical science.
[111] P. Kubes,et al. Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[112] B. Sheridan,et al. Physiological growth hormone secretion in adult growth hormone deficiency: comparison with normal controls , 1991, Clinical endocrinology.
[113] E. B. Pedersen,et al. Expansion of extracellular volume and suppression of atrial natriuretic peptide after growth hormone administration in normal man. , 1991, The Journal of clinical endocrinology and metabolism.
[114] C. Wiles,et al. Growth hormone treatment in growth hormone-deficient adults. I. Effects on muscle mass and strength. , 1991, Journal of applied physiology.
[115] A. E. El Nahas,et al. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. , 1991, Kidney international.
[116] B. Bengtsson,et al. Premature mortality due to cardiovascular disease in hypopituitarism , 1990, The Lancet.
[117] P. Sönksen,et al. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. , 1989, The New England journal of medicine.
[118] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[119] W C Willett,et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.
[120] P. Amer. Control of lipolysis and its relevance to development of obesity in man , 1988 .
[121] P. Björntorp,et al. The Influence of Body Fat Distribution on the Incidence of Diabetes Mellitus: 13.5 Years of Follow-up of the Participants in the Study of Men Born in 1913 , 1985, Diabetes.
[122] L. Wilhelmsen,et al. Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.
[123] R. DeFronzo,et al. The effect of growth hormone on glucose metabolism and insulin secretion in man. , 1982, The Journal of clinical endocrinology and metabolism.
[124] K. Alberti,et al. Hormonal and metabolic rhythms in Cushing's syndrome. , 1980, Metabolism: clinical and experimental.
[125] T. Merimee. A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. , 1978, The New England journal of medicine.
[126] G. Besser,et al. Cushing's syndrome. , 1972, Clinics in endocrinology and metabolism.
[127] P. Henneman,et al. Effects of human growth hormone in man. , 1960, The Journal of clinical investigation.
[128] C. Plotz,et al. The natural history of Cushing's syndrome. , 1952, The American journal of medicine.
[129] J. Jørgensen,et al. Long-term effects of growth hormone (GH) on body fluid distribution in GH deficient adults: a four months double blind placebo controlled trial. , 1999, European journal of endocrinology.
[130] A. Simon,et al. Predictive value of waist-to-hip ratio on cardiovascular risk events , 1999, International Journal of Obesity.
[131] S. Lamberts,et al. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. , 1997, The Journal of clinical endocrinology and metabolism.
[132] J. Devlin,et al. An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency. , 1996, European journal of endocrinology.
[133] J. Cunningham,et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. , 1995, The Journal of clinical endocrinology and metabolism.
[134] E D Lehmann,et al. Aortic compliance measurements using Doppler ultrasound: in vivo biochemical correlates. , 1993, Ultrasound in medicine & biology.
[135] A. Yergey,et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. , 1991, The Journal of clinical endocrinology and metabolism.
[136] W. Kannel,et al. Role of lipids and lipoprotein fractions in atherogenesis: the Framingham study. , 1981, Progress in lipid research.